TNXP Stock Sees Decline of Approximately -41.45% in Last Five Days

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tonix Pharmaceuticals Holding Corp shares valued at $9,000 were purchased by Treco James on Aug 20 ’25. At $36.00 per share, Treco James acquired 250 shares. The insider’s holdings grew to 250 shares worth approximately $9012.5 following the completion of this transaction.

Also, LEDERMAN SETH purchased 4,000 shares, netting a total of over 86,200 in proceeds. Following the buying of shares at $21.55 each, the insider now holds 4,005 shares.

As published in their initiating research note from Noble Capital Markets on April 18, 2022, Tonix Pharmaceuticals Holding Corp [TNXP] has been an Outperform. Analysts at ROTH Capital upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of August 18, 2017, ROTH Capital has increased its “Neutral” rating to a “Buy” for TNXP. Earlier on September 07, 2016, ROTH Capital downgraded its rating. Their new recommendation was “a Neutral” for TNXP stock which previously was a “a Buy”.

Analyzing TNXP Stock Performance

On last trading session, Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] plunged -1.31% to $36.05. The stock’s lowest price that day was $35.6, but it reached a high of $38.0 in the same session. During the last five days, there has been a drop of approximately -41.45%. Over the course of the year, Tonix Pharmaceuticals Holding Corp shares have dropped approximately -19.42%. Shares of the company reached a 52-week high of $69.97 on 08/14/25 and a 52-week low of $6.76 on 03/04/25.

Support And Resistance Levels for Tonix Pharmaceuticals Holding Corp (TNXP)

According to the 24-hour chart, there is a support level at 35.10, which, if violated, would cause prices to drop to 34.15. In the upper region, resistance lies at 37.50. The next price resistance is at 38.95. RSI (Relative Strength Index) is 40.45 on the 14-day chart, showing neutral technical sentiment.

Is Tonix Pharmaceuticals Holding Corp subject to short interest?

Stocks of Tonix Pharmaceuticals Holding Corp saw a sharp steep in short interest on 2025-07-31 dropping by 2994.0 shares to 1.21 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 1.21 million shares. A decline of -0.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.92 of the overall float, the days-to-cover ratio (short ratio) decline to 0.92.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.